MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE

View On IPO.GOV.AU

Removed - Not renewed: Renewal fee not paid

Last updated on 1 Feb 2023

Owner Info

Celgene Corporation a Delaware corporation

86 Morris Avenue

Summit, New Jersey,07901, UNITED STATES OF AMERICA

Serial Number

921136 filed on 24 Jul 2002

Correspondent

Banki Haddock Fiora

Level 22,

85 Castlereagh Street,

Sydney, NSW, 2000 AUSTRALIA

MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE

Classification Information

921136

24 Jul 2002

WORD

29 May 2002

Status Date	Action Taken
1^st Feb 2023	IP Right Ceased correspondence sent
1^st Feb 2023	Status change to Removed/Ceased - Not Renewed
29^th Jul 2022	Renewal Overdue correspondence sent
24^th May 2022	Renewal Reminder correspondence sent
9^th Feb 2012	Trade Marks Renewal Published
1^st Feb 2012	Renew Trade Mark
31^st Jan 2012	Renewal of Registration (1 class)
25^th Jul 2011	Registration Status Change
25^th Oct 2005	Amend Name/Address
21^st Oct 2005	Amend Trade Mark Registration Particulars